Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1Phase 2 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Infections 8Neoplasms 7Neutropenia 6Lymphoma 6Prostatic Neoplasms 5Leukemia 5Neoplasms, Plasma Cell 4Lymphoma, Non-Hodgkin 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Febrile Neutropenia 3Waldenstrom Macroglobulinemia 2Urinary Tract Infections 2Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Pancreatic Cyst 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Intraocular Lymphoma 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2

Interventions

Docetaxel 292Prednisone 241enzalutamide 195Leuprolide 185Radiotherapy 179Abiraterone Acetate 170Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 93abiraterone 83gallium 68 PSMA-11 81Specimen Handling 73darolutamide 67Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 53Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Ciprofloxacin × Clear all
NCT03862170 2025-02-12

BRP30

CR-CSSS Champlain-Charles-Le Moyne

Phase 3 Terminated
158 enrolled
Genitourinary

Prostatic Neoplasms

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed
1,538 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT02252978 2018-07-05

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Wake Forest University Health Sciences

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02247960 2017-04-17

Abx

University of Rochester

Phase NA Terminated
175 enrolled 7 charts
Genitourinary

Prostatic Neoplasms, Urinary Tract Infections

NCT01649635 2016-07-06

PROSPECTA

Sanofi

Phase 4 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡